Perella Weinberg Partners Capital Management LP Has $17.31 Million Stake in Express Scripts Holding Co (ESRX)

Perella Weinberg Partners Capital Management LP lifted its holdings in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 35.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 182,191 shares of the company’s stock after buying an additional 47,509 shares during the period. Perella Weinberg Partners Capital Management LP’s holdings in Express Scripts were worth $17,310,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of ESRX. Principal Financial Group Inc. increased its stake in Express Scripts by 17.4% in the 1st quarter. Principal Financial Group Inc. now owns 969,252 shares of the company’s stock valued at $66,956,000 after purchasing an additional 143,479 shares in the last quarter. CenturyLink Investment Management Co purchased a new position in Express Scripts in the 2nd quarter valued at approximately $1,741,000. Indiana Trust & Investment Management CO purchased a new position in Express Scripts in the 2nd quarter valued at approximately $1,879,000. DnB Asset Management AS purchased a new position in Express Scripts in the 2nd quarter valued at approximately $16,974,000. Finally, Burke & Herbert Bank & Trust Co. purchased a new position in Express Scripts in the 2nd quarter valued at approximately $285,000. 84.74% of the stock is owned by institutional investors and hedge funds.

In other news, insider Christine Houston sold 12,898 shares of the firm’s stock in a transaction on Friday, August 10th. The stock was sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the sale, the insider now owns 110,908 shares in the company, valued at $9,427,180. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.79% of the stock is owned by company insiders.

Express Scripts stock opened at $97.24 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.71 and a debt-to-equity ratio of 0.69. The firm has a market cap of $53.64 billion, a price-to-earnings ratio of 13.70, a P/E/G ratio of 1.20 and a beta of 1.01. Express Scripts Holding Co has a fifty-two week low of $59.17 and a fifty-two week high of $98.98.

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Wednesday, October 31st. The company reported $2.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.42 by $0.01. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The business had revenue of $25.56 billion for the quarter, compared to analysts’ expectations of $25.11 billion. During the same quarter last year, the firm earned $2.51 earnings per share. The business’s revenue was up 3.6% on a year-over-year basis. On average, research analysts anticipate that Express Scripts Holding Co will post 9.07 EPS for the current year.

Several equities analysts recently weighed in on ESRX shares. BidaskClub downgraded Express Scripts from a “buy” rating to a “hold” rating in a research note on Tuesday, July 10th. Credit Suisse Group downgraded Express Scripts from an “outperform” rating to a “neutral” rating and raised their price objective for the company from $90.00 to $96.50 in a research note on Tuesday, September 18th. Maxim Group reaffirmed a “hold” rating on shares of Express Scripts in a research note on Thursday. Royal Bank of Canada raised their price objective on Express Scripts to $94.00 and gave the company an “outperform” rating in a research note on Monday, August 27th. Finally, Barclays raised their price objective on Express Scripts from $83.00 to $90.00 and gave the company an “equal weight” rating in a research note on Thursday. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $88.79.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Further Reading: Closed-End Mutual Funds

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply